BDA-366

98%

  • Product Code: 107754
  CAS:    1821496-27-8
Molecular Weight: 423.5 g./mol Molecular Formula: C₂₄H₂₉N₃O₄
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: -20°C, airtight, dry
Product Description: BDA-366 is primarily researched for its potential applications in cancer therapy. It functions as a BH4 domain antagonist, specifically targeting Bcl-2, a protein that plays a critical role in regulating cell death. By inhibiting Bcl-2, BDA-366 promotes apoptosis in cancer cells, making it a promising candidate for treating cancers that overexpress Bcl-2, such as certain types of leukemia and lymphoma. Its ability to selectively induce cell death in malignant cells while sparing normal cells highlights its potential as a targeted therapeutic agent. Ongoing studies are focused on optimizing its efficacy and safety profile for clinical use.
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.010 10-20 days ฿29,376.00
+
-
BDA-366
BDA-366 is primarily researched for its potential applications in cancer therapy. It functions as a BH4 domain antagonist, specifically targeting Bcl-2, a protein that plays a critical role in regulating cell death. By inhibiting Bcl-2, BDA-366 promotes apoptosis in cancer cells, making it a promising candidate for treating cancers that overexpress Bcl-2, such as certain types of leukemia and lymphoma. Its ability to selectively induce cell death in malignant cells while sparing normal cells highlights its potential as a targeted therapeutic agent. Ongoing studies are focused on optimizing its efficacy and safety profile for clinical use.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: ฿0.00
฿0.00 Total :